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Background: Multiple sclerosis can impair cognition from the early stages and has been shown to be
associated with gray matter damage in addition to white matter pathology.
Objectives: To investigate the profile of cognitive impairment in clinically isolated syndrome (CIS), and
the contribution of cortical inflammation, cortical and deep gray matter atrophy, and white matter le-
sions to cognitive decline.
Methods: Thirty patients with clinically isolated syndrome and twenty demographically- matched
healthy controls underwent neuropsychologic assessment through the Rao Brief Repeatable Battery, and
brain magnetic resonance imaging with double inversion recovery using a 3T scanner.
Results: Patients with clinically isolated syndrome performed significantly worse than healthy controls
on tests that evaluated verbal memory, visuospatial learning and memory, and verbal fluency. Significant
deep gray matter atrophy was found in the patients but cortical volume was not lower than the controls.
Visual memory tests correlated with the volume of the hippocampus, cerebral white matter and deep
gray matter structures and with cerebellar cortical atrophy. Cortical or white matter lesion load did not
affect cognitive test results.
Conclusion: In our patients with CIS, it was shown that cognitive impairment was mainly related to
cerebral white matter, cerebellar cortical and deep gray matter atrophy, but not with cortical in-
flammation, at least in the early stage of disease.
& 2016 Elsevier B.V. All rights reserved.1. Introduction
Cognitive impairment may be present during the early stages of
multiple sclerosis (MS) (Achiron and Barak, 2003) with a pre-
valence ranging from 40% to 70% (Amato et al., 2006). It has a
dramatic impact on personal, social and occupational function
(Amato et al., 2006). MS-related cognitive deterioration is char-
acterized by involvement of recent memory, sustained attention,
information processing speed, and executive function (Rao et al.,
1991). The Brief Repatable Battery of Neuropsychological Tests
(BRBN) assesses cognitive domains that are most frequently im-
paired in MS and incorporates tests of verbal memory, visual
memory, attention, concentration, speed of informationS. Diker),
gmail.com (A. Kurne),
.com (K.K. Oğuz),processing, and verbal fluency (Rao et al., 1991). Although cogni-
tive profile has interpatient heterogenicity, information processing
speed is generally accepted as the mostly affected cognitive do-
main in MS (DeLuca et al., 2004; Tekok-Kilic et al., 2007).
Recent studies showed that brain atrophy assesment was a
better predictor of cognitive impairment in MS than lesion burden
(Benedict et al., 2004; Bermel and Bakshi, 2006). Although the
relationship between cognitive deterioration and subcortical
white matter (WM) pathology remains controversial (Benedict
et al., 2004; Rovaris et al., 2000; Rao et al., 1989), there is in-
creasing evidence of a primary role of cortical pathology in de-
termining cognitive disability (Tekok-Kilic et al., 2007; Portaccio
et al., 2006; Benedict et al., 2006a,b). Gray matter (GM) atrophy
appears to have unique, (Sanfilipo et al., 2006) if not greater
(Dalton et al., 2004; Bakshi et al., 2005) clinical significance than
WM lesions and/or volume. GM atrophy is more strongly related
to cognitive decline, especially when the cerebral cortex is as-
sessed (Benedict et al., 2006a,b; Amato et al., 2004). Besides cor-
tical atrophy, cortical lesion load was recently shown to be
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ese et al. (2012). Increased ability of detection of cortical lesions in
MS by double inversion recovery (DIR) sequences has been shown
previously (Wattjes et al., 2007).
In this study, we assessed the extent and the most affected
domains of cognitive impairment and its probable correlations
with GM pathology in a clinical cohort of patients with clinically
isolated syndrome (CIS) who presented with a first episode sug-
gestive of MS.2. Materials and methods
2.1. Participants
Thirty patients with CIS were studied [20 women and 10 men,
mean age7standard deviation (SD) 31.478.5 years]. The re-
cruited patients had been followed up at the neuroimmunology
clinic of Hacettepe University Hospital between 2012 and 2014.
McDonald's criteria were used for the diagnosis of CIS. Patients
with visual or upper limb involvement that would interfere with
neuropsychologic testing, other neurologic disease, major systemic
disease, major psychiatric illness, drug or alcohol addiction, any
drug use that could interfere with cognitive function were ex-
cluded from the study. All patients were relapse free and had not
taken any steroids for at least 1 month before the assessment
(mean disease duration7SD 11.8715.5 months; range, 1–76
months). Eight (26.7%) of the 30 patients were under treatment
with beta-interferons or glatiramer acetate at the time of study
entry. For each patient, a neurologic evaluation including disability
rating on the Expanded Disability Status Scale (EDSS) and cogni-
tive assessment using the BRBN were performed within a week of
magnetic resonance imaging (MRI) acquisition. None of the pa-
tients had any treatment procedure changes during this interval.
The test performances and MRI results of the patients were
compared with those of 20 demographically-matched healthy
controls (7 men and 13 women, mean age7SD 32.2578.58 years)
who were recruited among healthy volunteers with a normal
neurologic examination and with no history of neurologic dis-
orders. The study was approved by the Ethics Committee of the
Faculty of Medicine of Hacettepe University, and written informed
consent was obtained from all participating subjects.
2.2. Clinical and neuropsychologic assessment
Depression was evaluated and excluded with the Beck's De-
pression Scale (Beck et al., 1961). The performance on each test of
the BRBN was assessed by applying the available Turkish norma-
tive values, which for each test provided a mean test score (7SD)
obtained from 106 healthy individuals who were grouped by sex,
age (15-30, 31-45, 46-60) and education level (o7 years, 7-12
years, 412 years) (Bingol and Tütüncü, 2010). In particular, we
defined the failure of a test when the score was at least 2 SDs
below the corresponding mean normative value. Patients who
failed at least two tests were considered cognitively impaired, and
those who failed fewer than two tests were considered cognitively
preserved. In brief, the BRBN consists of the following subtests:
1. The Selective Reminding Test (SRT), (Ehrenreich, 1995) which
tests for verbal learning and memory using a list of 12 words. From
up to six test trials, a total learning score (SRT-TL) is achieved, plus
after 25 min, a score for delayed recall (SRT-DR) is generated.
2. The 10/36-Spatial Recall Test (SPART) (Boringa et al., 2001)
measures visuospatial learning and memory. Participants try to
recall the location of 10 checkers that are randomly placed on a
66 checkerboard. The sum of the correct responses in the three
immediate recall trials (total learning, SPART-TL), and the delayedrecall after 15 min (SPART-DR) are recorded.
3. The Symbol Digit Modalities Test (SDMT) (Smith, 1991)
measures information processing speed, sustained attention, and
concentration. Subjects are given 90 s to substitute symbols for
numbers as part of a set code.
4. The Paced Auditory Serial Addition Test (3 s version; PASAT3)
(Gronwall, 1977) examines sustained attention, working memory,
and information processing speed by evaluating an addition task
regarding acoustically presented digits at a rate of 3 s per digit.
5. Word List Generation (WLG), (Rao et al., 1991) which mea-
sures verbal fluency on semantic stimulus by evaluating the
spontaneous production of words in a given category within 90 s.
The BRBN, which has been translated and validated in Turkish,
(Bingol and Tütüncü, 2010) was applied in a standardized, single-
test session in the following order: SRT-TL, SPART-TL, SDMT, PA-
SAT3, SRT-DR, SPART-DR, and WLG, and lasted for approximately
30–45 min.2.3. MR examination and analysis
A cranial MRI examination of each participant was performed
in the same week as the neuropsychologic examination using a 3T
scanner (Magnetom, Trio Tim, Siemens) in the National MR Re-
search Center (UMRAM, Bilkent University, Ankara). The MRI
protocol included axial T1-weighted (W) (TR/TE; 500/10 msec),
FLAIR (TR/TE/TI; 9000/97/2499.5 msec , slice thickness (ST)/inter-
slice gap (IG): 4.0/0.8 mm), T2W (TR/TE; 4800/92 msec, ST/IG; 4.0/
0.8 mm) imaging. To better delineate the lesions, a sagittal double-
inversion recovery sampling perfection with application optimized
contrasts using different flip angle evolution (DIR SPACE) sequence
(TR/TE/TI: 7500/325/3000 msec, ST/IG; 1.12/0 mm, FOV: 215215,
matrix: 192192) was also applied. The total MRI took about
30 min. No medication or contrast agent was used.
We used Freesurfer version 5.3.0 (http://surfer.nmr.mgh.har
vard.edu/) volumetric segmentation to obtain regional measures
of cortical volumes (mm3), including the removal of non-brain
tissue (skull, eyeballs, and skin), with an automated algorithm
with the ability to segment the whole brain without any user in-
tervention, and cortical surface reconstruction methods. Fischl
et al. (2002) previously described the automated procedures for
volumetric measures of the different brain structures. The re-
constructed cortical surface models for each participant were
checked to confirm segmentation accuracy and regions with poor
segmentation accuracy resulting from poor image quality or mis-
registration were excluded. Cortical surfaces were automatically
parcellated and combined to constitute the average cortical vo-
lume for total GM and for frontal, temporal, parietal, and occipital
lobes. Each patient's intracranial volume was used to normalize
the constituted regions. The volume of T1 hypointense lesions was
also calculated using Freesurfer. Each volume of region was nor-
malized to each patient's intracranial total brain volume.
We used BrainVoyager QX 2.6 for Linux (http://www.brain
voyager.com) to record the coordinations of each hyperintense
WM and GM lesion on DIR SPACE imaging. The lesions were ran-
ged using a bounding box in which all the intensities of voxels
were fixed to a threshold for a clear visual distinction of lesions
and parenchyma (http://support.brainvoyager.com/volumespace/
107-volume-rendering/314-users-guide-masking-and-cutting.
html). The number and total volume of the voxel-of-interest (VOI)
s, thus lesions visible on DIR SPACE imaging were calculated. In
this way, it was aimed to determine the demyelinating hyper-
intense lesion load in respect to the number and volume of lesions
in patients with CIS.
Table 1
Demographic characteristics of study population ( ON : optic neuritis, TM : trans-
verse myelitis, IgGOB: immunoglobulin G oligoclonal band, CSF: cerebrospinal fluid,
EDSS: Expanded Disability Status Scale).
Characteristics CIS (n:30) Healthy con-
trols (n:20)
p value
Female to male ratio 20:10 13:7 NS




















Attack type, No. (%)
ON 9 (30) –
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As descriptive statistics for numerical measures mean 7SD,
median, minimum and maximum values were used. For qualita-
tive measures, number and percent were given. The Shapiro-Wilk
test was used to test whether distributions of measures of the
patient and control group were normal. As the measures did not
show a normal distribution, the 2 groups were compared using the
Mann-Whitney U test. Spearman's correlation and partial corre-
lation analysis were used to show the relationship between
measures with significance set at po0.05. Since the study covered
multiple statistical analyses, False Discovery Rate (FDR) approach
was applied for controlling statistical errors. FDR threshold was
accepted to be 0.05 and the FDR method was performed with ‘
fdrtool’ package in R statistical software ( version 3.1.3). All sta-
tistical analyses were carried out using IBM-SPSS version 21.0.TM 11 (36.7)
Brainstem/cerebellar 6 (20)
Cerebral 4 (13.3)
IgGOBs in CSF, No.(%) 28 (93.3) –
No. receiving therapy




0 24 (80) –
1 6 (20)
Table 2
Comparison of cognitive test scores of the groups.





Beck 5.4072.527(1–9) 3.9571.504 (2–7) 0.031
SRT-TL 51.6377.388 (33–65) 55.5575.306 (47–69) 0.101
SRT-DR 9.071.912 (3–11) 10.1571.565 (7–12) 0.035
SPART-TL 16.0374.635 (9–27) 19.1074.012 (11–26) 0.013
SPART-DR 5.4372.144 (2–10) 6.9071.774 (4–10) 0.011
SDMT 42.90711.923 (20–68) 48.45713.516 (20–75) 0.178
PASAT3′ 39.10717.271 (0–60) 44.95713.858 (0–60) 0.258
WLG 24.5775.418 (15–34) 30.40710.831 (20–70) 0.0253. Results
Main characteristics of patients with CIS and controls are de-
tailed in Table 1.
3.1. Neuropsychologic performance
Only 2 patients out of the whole sample of 30 patients with CIS
were diagnosed as having cognitive impairment if the reliable
definition is used as abnormal test results in Z2 tests using a cut-
off value of Z2 SDs below the mean of normative values. Rather
than comparing 28 patients who were cognitively preserved with
the two who were cognitively impaired, differences between the
test results of the whole patient group and of the control group
were analyzed (Table 2). Beck depression scores were worse in the
patient group although it was below the cut-off level for mild
depression in both groups. As expected, the normal controls per-
formed better than patients with CIS in all neuropsychologic tests,
although this difference was significant for SRT-DR, SPART-TL,
SPART-DR and WLG (po0.05 for all measures). In the patient
group, although age or age at disease onset was not found a pre-
dicting factor of any test result, education years had correlations
with all tests. Disease duration had correlations with SPART-TL and
SPART-DR tests. However, performances of SPART-TL, SPART-DR,
SDMT and PASAT worsened in the control group as age progressed.
Education years had correlations with WLG, SPART-TL and SDMT in
the control group. Correlations of the test results with clinical and
demographic data are summarized in Table 3.
3.2. MRI findings
MRI characteristics of the two groups are summarized in Ta-
ble 4. Volumes of each putamen, right caudate and right pallidum
were lower, whereas the volume of the third ventricle was higher
in the CIS group than in the control group (po0.05 for all mea-
sures). No differences in the cortical GM, cerebral WM, and tha-
lamic volumes were found between each group (p40.05 for all
measures). On DIR SPACE images, the mean WM lesion number
was 10.5077.459 (mean7SD, range 0–31) and the volume was
2.9975.58 cm3 (mean7SD). Seven patients (23.3%) showed de-
myelinating lesions in deep GM. WM lesion load or deep GM le-
sions had no relationship with age, age at disease onset or disease
duration (p40.05 for all measures).
Cortical lesions on 3D DIR were detected in 23 (76.6%) patients
(Fig. 1). These lesions were either supra- or infratentorial, and
mostly located in the frontal and temporoparietal cortices, re-
spectively. The mean cortical lesion number was 5.675.75
(mean7SD) and volume was 223.137374.21 mm3 (mean7SD);age, age at disease onset or disease duration had no effect on these
two measures (p40.05 for all measures).
There was not any statistically significant correlation between
cortical lesion number/volume and cortical GM volume (p40.05).
As summarized in Table 5, the patients with cortical lesions
(n¼23) were found to have higher WM lesion numbers and vo-
lume (po0.01 for all measures) when compared with patients
who had no cortical lesions (n¼7). Cortical GM volume did not
differ between the two groups (p40.05).
3.3. MRI measures and cognitive test results
We analyzed the volumetric correlations of the cognitive tests
that showed significant differences in performance between pa-
tients with CIS and controls. In the patient group, SPART-TL per-
formance had correlations with total GM volume (po0.01), and
total cortical GM volume, subcortical GM volume and cerebellar
cortical volume (po0.05 for all). When adjusted for age, disease
duration and education years, none of these correlations remained
significant (p40.05). SPART-DR test performance significantly
correlated with subcortical GM volume and cerebellar cortical
volume (po0.01) and to a lesser extent with total GM, hippo-
campus, cerebral WM volume (po0.05). When adjusted for age,
disease duration and education years, correlations between
SPART-DR and cerebral WM volume, cerebellar cortical volume,
Table 3
Correlation of cognitive test results and demographical data.









Beck 0.022 0.042 0.053 0.065 0.204 0.211
0.909 0.825 0.783 0.733 0.387 0.373
SRT-TL 0.254 0.370* 0.261 0.138 0.420 0.085
0.176 0.044 0.164 0.467 0.065 0.721
SRT-DR 0.225 0.397* 0.222 0.025 0.184 0.060
0.232 0.030 0.239 0.896 0.436 0.801
SPART-TL 0.206 0.550** 0.180 0.399* 0.554* 0.532*
0.274 0.002 0.342 0.029 0.011 0.016
SPART-DR 0.304 0.549** 0.238 0.432* 0.508* 0.241
0.102 0.002 0.204 0.017 0.022 0.307
SDMT 0.228 0.542** 0.248 0.101 0.526** 0.478*
0.226 0.002 0.185 0.597 0.017 0.033
PASAT3′ 0.353 0.704** 0.337 0.151 0.454* 0.426
0.055 0.000 0.068 0.426 0.044 0.061
WLG 0.168 0.458* 0.215 0.035 0.324 0.721**
0.374 0.011 0.254 0.854 0.164 0.000










L cortical GM 223.87261.9 232.17370.6 0.464
R cortical GM 221.57254.6 230.57355.1 0.440
Total cortical GM 443.67513.4 462.97733.1 0.383
L caudate 4.5476.31 3.6670.49 0.113
R caudate 3.4770.60 3.9170.94 0.017
L putamen 5.4370.98 6.3170.86 0.007
R putamen 5.3370.93 6.1770.94 0.008
L pallidum 1.70 70.24 1.617 0.22 0.476
R pallidum 1.3970.20 1.5670.17 0.005
Total GM 598.27118.4 633.1783.6 0.259
3rd ventricle 1.1470.26 0.8270.21 o0.001
L cerebellar cortex 48.775.98 49.6 74.97 0.332
R cerebellar cortex 50.275.34 51.77 4.60 0.243
L cerebral WM 242.77480.7 316.77416.2 0.303
R serebral WM 243.47487.9 223.17188.1 0.092
L cerebellar WM 14.472.54 15.171.40 0.227
R cerebellar WM 18.6719.4 15.171.24 0.859
L hippocampus 4.1070.42 4.0670.48 0.890
R hippocampus 4.1570.60 4.3070.45 0.546
R: right, L: left, WM : white matter, GM: gray matter.
S. Diker et al. / Multiple Sclerosis and Related Disorders 10 (2016) 14–21 17and hippocampus volume remained significant (po0.05 for all
measures) . WLG and SRT-DR tests did not show any correlations
with volumetric measures (Table 6). No relationship was found
between cognitive test performances and WM lesion load or cor-
tical lesion load (p40.05 for all measures) (Table 7). In the control
group, after adjustment for age and education years, no positive
correlation was found between cognitive test results and volu-
metric measures (Table 8) . When FDR approach was applied to the
unadjusted p values, correlation between SPART-DR and sub-
cortical gray matter volume remained significant (FDR adjusted p :
0.04), while FDR adjusted p value was equal to 0.05 for the cor-
relation between SPART-DR and cerebellar cortical volume, and
higher than 0.05 for the rest of the correlations. When FDR cor-
rection was applied to p values adjusted for age, disease duration
and education years, none of the correlations survived ( FDRadjusted p40.05 for all).4. Discussion
The prevalence of cognitive impairment in our CIS group (6.6%)
was actually low when compared with rates in the literature,
which range from 18% to 57%, (Feuillet et al., 2007; Khalil et al.,
2011) and 40% to 70% (Rao et al., 1991; Benedict et al., 2006a,b)
according to different reference criteria for CIS and MS, respec-
tively. This might be due to the stringent criteria we used while
analyzing the tests and the relatively short disease duration of our
patients. In agreement with our findings, Khalil et al. (2011), who
studied CIS patients with a mean disease duration of 0.2 years,
found 2 out of 44 patients as cognitively impaired when using
similar cut-off values. As a consequence, these small numbers
precluded a comparison of cognitively-impaired versus cogni-
tively-preserved patients, so the test results were compared be-
tween the whole CIS group and the control group.
Generally, information processing speed seems to be the most
commonly affected cognitive domain in MS (DeLuca et al., 2004;
Janculjak et al., 2002; Bergendal et al., 2007). However, the pattern
of cognitive impairment varies as the disease progresses and the
dominantly affected domain in the CIS population is conflicting. In
our study, patients with CIS did not differ from the controls on the
basis of PASAT and SDMT test performances, which measure the
information processing speed. However, when compared with the
controls, the patients with CIS scored significantly lower in visual
memory, verbal memory, and semantic verbal fluency tasks, which
were examined using SPART-DR and SPART-TL, SRT, and WLG tests,
respectively. There are studies in the early stages of the disease
with results that support our findings. In a group of 67 patients
who were diagnosed as having probable MS, Achiron and Barak
(2003) reported that the most frequently affected cognitive do-
main was visual learning and recall, followed by semantic verbal
fluency. In our study, visual memory tasks were the most sig-
nificantly impaired fields in the patient group when compared
with the controls. Stage of the disease, which was relatively early
in our patients, might be the reason for sparing of information
processing speed with worsening visual memory, and cognitive
profile is expected to widen as the disease progresses.
As regards to GM damage, we found significant deep GM
atrophy without evidence of cortical atrophy in the CIS group
when compared with the control group. Regional analysis of
subcortical structures evidenced a significant atrophy that in-
volved the right caudate, right pallidum, and bilateral putamen,
and a significant enlargement of the third ventricle in the CIS
group. Our findings of cortical GM sparing with prominent atrophy
in deep GM are partly against the widely accepted conception that
atrophy occurs from the earliest phase of disease, both at sub-
cortical (Bergsland et al., 2012) and cortical levels (Calabrese et al.,
2007a, b). However, there are studies in parallel with ours that
found deep GM changes before prominent cortical atrophy existed
(Bergsland et al., 2012; Henry et al., 2008).
In our patients with CIS, compared with the healthy controls,
spatial recall tests were the most significantly worsened cognitive
test performances. When we examined the volumetric correla-
tions of worsening visuospatial abilities, we found that cerebellar
cortical volume was one of the predictors of visuospatial memory
in the patient group. Cerebellar cortical volume, although not
statistically significant, was lower in the patient group. To our
knowledge, this study is the first to explore the impact of cere-
bellar cortical pathology on visuospatial cognitive tasks in patients
with CIS. Besides its well known motor functions, the role of the
cerebellum in cognitive tasks and its reciprocal interactions with
the cerebral cortex has been shown in functional MRI and
Fig. 1. Sagittal 3D DIR SPACE images obtained from four different patients show cortical/juxta-cortical hyperintense demyelinating lesions (arrows).
Table 5






Age 33.179.8 30.978.2 40.05
Age at disease
onset
32.37 9.5 30.077.6 40.05







IgGOBs in CSF No.
(%)
7 (100%) 21 (91.3%) 40.05
WM: white matter, IgGOB: immunoglobulin G oligoclonal band, CSF: cerebrospinal
fluid.
Table 6
Correlation of cognitive test results and volumetric measures in patients with CIS
after adjustment for age, disease duration and education years.
MRI Measure SRT-DR SPART-TL SPART-DR WLG
Total cortical GM r 0.086 0.158 0.104 0.141
p 0.669 0.432 0.606 0.483
Subcortical GM r 0.018 0.101 0.201 0.029
p 0.927 0.617 0.315 0.885
Cerebellar Cortex (LþR) r 0.039 0.351 0.479 0.058
p 0.848 0.073 0.012* 0.775
Hippocampus (LþR) r 0.128 0.354 0.473 0.151
p 0.525 0.070 0.013* 0.453
Cerebral WM (LþR) r 0.154 0.246 0.459 -0.045
p 0.443 0.216 0.016* 0.825
r: Spearman correlation coefficient-corrected, GM: gray matter, WM: white matter,
L: left, R: right.
* po0.05.
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tribution of the cerebellum in memory, auditory, and language
functions; visual locomotion and face perception; emotional pro-
cessing; and social cognition has been implicated. (Sokolov et al.,
2014; Stoodley and Schmahmann, 2009; Petersen et al., 1989;
Table 7
Correlation of cognitive test results and lesion load measures in patients with CIS.
MRI measure SRT-TL SRT-DR SPART-TL SPART-DR SDMT PASAT WLG
WM lesion number r 0.076 0.196 0.100 0.060 0.053 0.098 0.179
p 0.690 0.300 0.600 0.753 0.783 0.606 0.343
WM lesion volume r 0.258 0.098 0.132 0.157 0.066 0.145 0.358
p 0.169 0.607 0.487 0.407 0.728 0.445 0.052
Cortical lesion number r 0.284 0.134 0.032 0.029 0.009 0.029 0.195
p 0.129 0.479 0.866 0.878 0.964 0.878 0.302
Cortical lesion volume r 0.184 0.055 0.040 0.054 0.007 0.050 0.241
p 0.331 0.774 0.832 0.778 0.973 0.794 0.199
r: Spearman correlation coefficient, WM: white matter.
Table 8
Correlation of cognitive test results and volumetric measures after adjustment for age and education years in healthy controls.
MRI measure SRT-TL SRT-DR SPART-TL SPART-DR SDMT PASAT WLG
Total cortical GM r 0.391 0.530 0.232 0.020 0.088 0.203 0.024
p 0.109 0.024 0.354 0.937 0.729 0.420 0.923
Subcortical GM r 0.483 0.022 0.364 0.133 0.269 0.015 0.251
p 0.042 0.932 0.137 0.598 0.280 0.954 0.316
Total GM r 0.510 0.527 0.311 0.004 0.153 0.204 0.105
p 0.031 0.025 0.208 0.987 0.545 0.417 0.677
Cerebellar Cortex (LþR) r 0.556 0.452 0.378 0.050 0.002 0.202 0.154
p 0.017 0.059 0.122 0.843 0.994 0.422 0.542
Hippocampus (LþR) r 0.405 0.416 0.082 0.157 0.248 0.165 0.135
p 0.096 0.086 0.748 0.534 0.322 0.513 0.593
Cerebral WM (LþR) r 0.342 0.016 0.254 0.083 0.008 0.067 0.194
p 0.165 0.948 0.308 0.743 0.975 0.791 0.441
r: Spearman correlation coefficient- corrected, GM: gray matter, WM: white matter, L: left, R: right.
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that investigated the contribution of cerebellar GM and WM vo-
lume to SDMT and PASAT tests in patients with MS, cerebellar
atrophy was shown to have no direct effect on the test perfor-
mances (Weier et al., 2014). In our study, we found a contribution
of cerebellar cortical integrity to visual memory tasks in the CIS
group and follow-up of our patients will show whether this im-
pact increases with disease progression.
Atrophy of deep GM structures and its contribution to spatial
recall test performances in patients with CIS were the other im-
portant findings of our study. In previous studies, deep GM atro-
phy was found to be predictive of cognitive decline in patients
with MS (Benedict et al., 2013; Benedict et al., 2009). In our study,
although not remaining significant after adjustment for con-
founding factors, SPART scores, especially SPART-DR, showed cor-
relations with subcortical GMV.
Although in the literature thalamus and hippocampus atrophy
have been shown to be related with slow verbal fluency, (Su-
mowski et al., 2009) we found no MRI correlations with WLG test
results. Similarly, the other test that was scored more poorly by
the patient group; SRT-DR, which evaluates long-term verbal
memory, had no relation with volumetric measures.
We considered cortical lesion number/volume and cortical GM
volume separately because the basis of GM atrophy in MS is not
clearly understood. While primary damage of the GM, such as GM
plaques that induce demyelination is one of the underlying me-
chanisms, GM atrophy can also be secondary to axonal transection
in the WM plaques, normal appearing WM changes or GM in situ
processes (Sepulcre et al., 2009; Bruck, 2005; Perry and Anthony,
1999). In parallel with this, we did not find any statistically sig-
nificant correlation between cortical GM volume and cortical le-
sion number/volume.We detected cortical lesions in 23 (76.6%) of our patients. These
patients had significantly higher WM lesion load when compared
with patients who had no evidence of cortical lesions. Age, disease
duration or age at disease onset showed no correlation with cor-
tical lesion load. In the literature, prevalence of cortical lesions in
the CIS population was found to be 37–40% using DIR-MRI (Ca-
labrese et al., 2007a,b; Lucchinetti et al., 2011) and higher WM
lesion volume and oligoclonal band positivity were detected as
risk factors (Calabrese et al., 2007a,b). The high frequency of cor-
tical lesions in our study group may be explained both by the
presence of a significant number of patients with oligoclonal
bands and their high WM lesion load.
As previously evidenced by Achiron and Barak (2003), the total
lesion burden, whether in cortical or subcortical GM or WM, was
not correlated with any cognitive task performances in patients
with CIS. Our main results indicated that subcortical GM and WM
volume were more closely related to neuropsychologic perfor-
mance compared with lesion burden. However the pathologic
specificity for 3D DIR to detect cortical lesions is 90%, while its
sensitivity is only 18% in total, 83% for mixed type lesions, 8% for
intracortical lesions and 7% for subpial lesions (Geurts et al., 2005).
The low detection rate of cortical lesions with DIR might be an
explanation of the lack of a correlation between cortical lesion
load and cognitive test results in our study.
Our study had limitations that should be taken into account.
We did not analyse whether regional cortical or lobar volume af-
fected cognitive function. In addition, our study was cross-sec-
tional based on a modest sample of 30 patients. We are currently
evaluating additional patients in order to obtain sufficient follow-
up data. Another limitation is that, correlations between a number
of cognitive test scores and brain volume/lesion measures were
studied. This causes a multiple testing problemwith such a sample
S. Diker et al. / Multiple Sclerosis and Related Disorders 10 (2016) 14–2120size. In order to minimize this problem and make our study sta-
tistically stronger, we combined the MRI measures into bilateral
measures where there was a high correlation between left and
right side, allowing to reduce data dimensionality and we also
applied FDR approach for the correlations.
In our study, we found that disease duration and educational
years had contributions to some of the cognitive test scores, while
age affected some volumetric measures of the brain. So while
analyzing the correlations between test performances and volu-
metric measures, we controlled for these confounding factors. By
this way, we confirmed the accuracy of the correlations we found.
However a disadvantage of this method was that some correla-
tions did not remain significant after adjustment which was the
case for subcortical GM atrophy and its relation to worsening vi-
suospatial memory. Also when we applied FDR approach to the
adjusted p values, correlation between SPART-DR and subcortical
gray matter volume did not remain statistically significant. The
relatively small sample size may play a role in the loss of the
statistical significance of these correlations after adjustment.
In conclusion, despite the high prevalence of cortical lesions in
our patients, cognitive impairment was mainly related with cer-
ebral WM and deep GM atrophy, and not with cortical in-
flammation, at least in the early stage of disease.
The significant WM lesion load of our patients did not interfere
with the cognitive test results. It is our impression that the atrophy
of both deep GM and WM, not the inflammatory lesions, is a
sensitive marker of cognitive impairment. The main cognitive
domain to be impaired in the patients with CIS was visual memory
and its relation to cerebellar cortical measures was noteworthy
and should be studied more extensively.Conflicts of interest
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